Algunos de los asteroides que Lucy visitará se encuentran aún a más de 530 millones de kilómetros de la nave espacial, lo que supone más del triple de la distancia media entre la Tierra y el Sol. Pero a pesar de la gran distancia y de los tamaños peque&ntild …
La sonda espacial Lucy observa de lejos asteroides que visitará Read More »
El helicóptero robótico Ingenuity de la NASA ha efectuado su vuelo número 50 en Marte. El Ingenuity, que es la primera aeronave en volar en otro mundo, realizó ese vuelo número 50 el 13 de abril, recorriendo más de 322,2 metros en 145,7 segundos. El …
Ondine Biomedical Inc. presented detailed results from its US Phase 2 BENEFIT-aPDT clinical trial to the 33rd European Congress of Clinical Microbiology and Infectious Diseases in Copenhagen, Denmark.
Ondine Biomedical’s Nasal Photodisinfection Cuts Surgical Site Infections by 66% Read More »
Nordic Nanovector ASA announces that full results from its Phase 2 clinical trials of Betalutin® in resistant/refractory indolent non-Hodgkin’s lymphoma have been published at EudraCT, the European Union Drug Regulating Authorities Clinical Trials Database of the European Union.
Biophytis SA announces the approval by a very large majority of all resolutions presented by the company and falling within the remit of the Combined General Meeting.
Biophytis: Results of the Combined General Meeting on April 17, 2023 Read More »
Biophytis SA announces its financial results for the year ended December 31, 2022, and provides updates on key perspectives for 2023.
Biophytis Announces 2022 Financial Results and 2023 Perspectives Read More »
Data of InnoCare’s robust oncology pipelines were presented at the 2023 American Association for Cancer Research Annual Meeting.
Data of InnoCare’s Robust Oncology Pipelines Presented at the 2023 AACR Annual Meeting Read More »
BerGenBio ASA announced that it presented data linking AXL activation to STK11 loss of function in Non-Small Cell Lung Cancer in an abstract titled, AXL as a Therapeutic Target in STK11 mutant NSCLC, at the American Association for Cancer Research Annual Meeting 2023.
BerGenBio Presents Data on STK11 Loss of Function and AXL Activation at AACR Read More »
AbbVie announced that the U.S. Food and Drug Administration has approved expanding the indication of QULIPTA® for the preventive treatment of migraine in adults.
U.S. FDA Approves QULIPTA® (atogepant) for Adults With Chronic Migraine Read More »
Carbios has accelerated its enzyme screening process with a microfluidic technology developed in partnership with the Paul Pascal Research Centre.
